Skip to main content
AYTU BIOPHARMA, INC logo

AYTU BIOPHARMA, INC — Investor Relations & Filings

Ticker · AYTU ISIN · US0547548745 US Manufacturing
Filings indexed 890 across all filing types
Latest filing 2026-02-17 Major Shareholding Noti…
Country US United States of America
Listing US AYTU

About AYTU BIOPHARMA, INC

https://aytubio.com/

Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics. The company concentrates on advancing innovative medicines for complex central nervous system (CNS) diseases, with a particular emphasis on treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and Major Depressive Disorder (MDD). Its business model involves identifying, acquiring, and commercializing new products to improve the quality of life for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-13 English
10-Q Filing
Interim / Quarterly Report Q2 2026
2026-02-03 English
8-K Filing
Regulatory Filings
2026-02-03 English
8-K Filing
Regulatory Filings
2026-01-20 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC by Aytu BioPharma, Inc. dated December 10, 2025. The key content is the submission of matters to a vote of security holders at the company's 2026 annual meeting, including detailed voting results for director elections, appointment of the independent auditor, and advisory vote on executive compensation. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at general meetings. The document is not an Annual Report, Audit Report, or Proxy Statement, but specifically reports voting outcomes. The length and content confirm it is not a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2025-12-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.